ロード中...
Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases
BACKGROUND: In breast cancer current guidelines do not recommend the routine use of serum tumour markers. Differently, we observed that CEA-TPA-CA15.3 (carcinoembryonic (CEA) tissue polypeptide (TPA) and cancer associated 115D8/DF3 (CA15.3) antigens) panel permits early detection and treatment for m...
保存先:
主要な著者: | , , , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
BioMed Central
2006
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1684262/ https://ncbi.nlm.nih.gov/pubmed/17116247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-6-269 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|